$VTAE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vitae Pharmaceuticals, Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Vitae Pharmaceuticals, Inc. Get notifications about new insider transactions in Vitae Pharmaceuticals, Inc for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 2015 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | A | 14.40 | 21,250 | 306,000 | 21,250 | |
| Feb 18 2015 | VTAE | Vitae Pharmaceutic ... | Morris Richard Steven | Chief Financial Off ... | Option Exercise | A | 14.40 | 15,000 | 216,000 | 15,000 | |
| Feb 18 2015 | VTAE | Vitae Pharmaceutic ... | Hatfield Jeffrey S. | Chief Executive Off ... | Option Exercise | A | 14.40 | 50,000 | 720,000 | 50,000 | |
| Feb 18 2015 | VTAE | Vitae Pharmaceutic ... | Fratamico Arthur | Chief Business Offi ... | Option Exercise | A | 14.40 | 13,750 | 198,000 | 13,750 | |
| Jan 26 2015 | VTAE | Vitae Pharmaceutic ... | Hatfield Jeffrey S. | Chief Executive Off ... | Option Exercise | M | 1.15 | 30,982 | 35,629 | 0 | |
| Jan 26 2015 | VTAE | Vitae Pharmaceutic ... | Hatfield Jeffrey S. | Chief Executive Off ... | Option Exercise | M | 1.15 | 8,115 | 9,332 | 0 | |
| Jan 26 2015 | VTAE | Vitae Pharmaceutic ... | Hatfield Jeffrey S. | Chief Executive Off ... | Buy | M | 1.15 | 30,982 | 35,629 | 430,401 | 399.4 K to 430.4 K (+7.76 %) |
| Jan 26 2015 | VTAE | Vitae Pharmaceutic ... | Hatfield Jeffrey S. | Chief Executive Off ... | Buy | M | 1.15 | 8,115 | 9,332 | 399,419 | 391.3 K to 399.4 K (+2.07 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | PROSPECT MANAGEMENT CO II LLC | 10% Owner | Option Exercise | C | 0.00 | 76,949 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | PROSPECT MANAGEMENT CO II LLC | 10% Owner | Option Exercise | C | 0.00 | 1,530,269 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | PROSPECT MANAGEMENT CO II LLC | 10% Owner | Option Exercise | C | 0.00 | 102,301 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | PROSPECT MANAGEMENT CO II LLC | 10% Owner | Option Exercise | C | 0.00 | 173,912 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | PROSPECT MANAGEMENT CO II LLC | 10% Owner | Option Exercise | C | 0.00 | 173,912 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | PROSPECT MANAGEMENT CO II LLC | 10% Owner | Buy | P | 8.00 | 671,807 | 5,374,456 | 2,572,523 | 1.9 M to 2.6 M (+35.34 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | PROSPECT MANAGEMENT CO II LLC | 10% Owner | Buy | C | 0.00 | 76,949 | 0 | 1,900,716 | 1.8 M to 1.9 M (+4.22 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | PROSPECT MANAGEMENT CO II LLC | 10% Owner | Buy | C | 0.00 | 1,530,269 | 0 | 1,823,767 | 293.5 K to 1.8 M (+521.39 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | PROSPECT MANAGEMENT CO II LLC | 10% Owner | Buy | C | 0.00 | 102,301 | 0 | 395,799 | 293.5 K to 395.8 K (+34.86 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | PROSPECT MANAGEMENT CO II LLC | 10% Owner | Buy | C | 0.00 | 261,977 | 0 | 293,498 | 31.5 K to 293.5 K (+831.12 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | PROSPECT MANAGEMENT CO II LLC | 10% Owner | Buy | C | 0.00 | 261,977 | 0 | 293,498 | 31.5 K to 293.5 K (+831.12 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Option Exercise | C | 0.00 | 1,031 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Option Exercise | C | 0.00 | 41,270 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Option Exercise | C | 0.00 | 9,285 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Option Exercise | C | 0.00 | 25,233 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Option Exercise | C | 0.00 | 1,009,414 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Option Exercise | C | 0.00 | 227,117 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Option Exercise | C | 0.00 | 3,563 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Option Exercise | C | 0.00 | 142,607 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Option Exercise | C | 0.00 | 32,086 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Buy | P | 8.00 | 15,446 | 123,568 | 47,077 | 31.6 K to 47.1 K (+48.83 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Buy | P | 8.00 | 617,868 | 4,942,944 | 1,883,372 | 1.3 M to 1.9 M (+48.82 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Buy | P | 8.00 | 139,019 | 1,112,152 | 423,754 | 284.7 K to 423.8 K (+48.82 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Buy | C | 0.00 | 1,031 | 0 | 31,631 | 30.6 K to 31.6 K (+3.37 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Buy | C | 0.00 | 41,270 | 0 | 1,265,504 | 1.2 M to 1.3 M (+3.37 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Buy | C | 0.00 | 9,285 | 0 | 284,735 | 275.5 K to 284.7 K (+3.37 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Buy | C | 0.00 | 25,233 | 0 | 30,600 | 5.4 K to 30.6 K (+470.15 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Buy | C | 0.00 | 1,009,414 | 0 | 1,224,234 | 214.8 K to 1.2 M (+469.89 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Buy | C | 0.00 | 227,117 | 0 | 275,450 | 48.3 K to 275.5 K (+469.90 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Buy | C | 0.00 | 5,367 | 0 | 5,367 | 0 to 5.4 K |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Buy | C | 0.00 | 214,820 | 0 | 214,820 | 0 to 214.8 K |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Buy | C | 0.00 | 48,333 | 0 | 48,333 | 0 to 48.3 K |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | Barrett Peter | Director | Option Exercise | C | 0.00 | 37,072 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | Barrett Peter | Director | Option Exercise | C | 0.00 | 1,099,743 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | Barrett Peter | Director | Buy | P | 8.00 | 37,500 | 300,000 | 1,174,315 | 1.1 M to 1.2 M (+3.30 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | Barrett Peter | Director | Buy | C | 0.00 | 37,072 | 0 | 1,136,815 | 1.1 M to 1.1 M (+3.37 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | Barrett Peter | Director | Buy | C | 0.00 | 1,099,743 | 0 | 1,099,743 | 0 to 1.1 M |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Option Exercise | C | 0.00 | 1,031 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Option Exercise | C | 0.00 | 41,270 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Option Exercise | C | 0.00 | 9,285 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Option Exercise | C | 0.00 | 25,233 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Option Exercise | C | 0.00 | 1,009,414 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Option Exercise | C | 0.00 | 227,117 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Option Exercise | C | 0.00 | 3,563 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Option Exercise | C | 0.00 | 142,607 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Option Exercise | C | 0.00 | 32,086 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Buy | P | 8.00 | 15,446 | 123,568 | 47,077 | 31.6 K to 47.1 K (+48.83 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Buy | P | 8.00 | 617,868 | 4,942,944 | 1,883,372 | 1.3 M to 1.9 M (+48.82 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Buy | P | 8.00 | 139,019 | 1,112,152 | 423,754 | 284.7 K to 423.8 K (+48.82 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Buy | C | 0.00 | 1,031 | 0 | 31,631 | 30.6 K to 31.6 K (+3.37 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Buy | C | 0.00 | 41,270 | 0 | 1,265,504 | 1.2 M to 1.3 M (+3.37 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Buy | C | 0.00 | 9,285 | 0 | 284,735 | 275.5 K to 284.7 K (+3.37 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Buy | C | 0.00 | 25,233 | 0 | 30,600 | 5.4 K to 30.6 K (+470.15 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Buy | C | 0.00 | 1,009,414 | 0 | 1,224,234 | 214.8 K to 1.2 M (+469.89 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Buy | C | 0.00 | 227,117 | 0 | 275,450 | 48.3 K to 275.5 K (+469.90 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Buy | C | 0.00 | 5,367 | 0 | 5,367 | 0 to 5.4 K |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Buy | C | 0.00 | 214,820 | 0 | 214,820 | 0 to 214.8 K |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Buy | C | 0.00 | 48,333 | 0 | 48,333 | 0 to 48.3 K |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | Gunderson Robert V JR | Director | Option Exercise | C | 0.00 | 4,454 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | Gunderson Robert V JR | Director | Option Exercise | C | 0.00 | 4,347 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | Gunderson Robert V JR | Director | Buy | C | 0.00 | 4,454 | 0 | 11,002 | 6.5 K to 11 K (+68.02 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | Gunderson Robert V JR | Director | Buy | C | 0.00 | 6,548 | 0 | 6,548 | 0 to 6.5 K |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | NEW ENTERPRISE ASSOCIATES 10 L ... | 10% Owner | Option Exercise | C | 0.00 | 58,692 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | NEW ENTERPRISE ASSOCIATES 10 L ... | 10% Owner | Option Exercise | C | 0.00 | 1,479,058 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | NEW ENTERPRISE ASSOCIATES 10 L ... | 10% Owner | Option Exercise | C | 0.00 | 172,825 | 0 | 0 | |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | NEW ENTERPRISE ASSOCIATES 10 L ... | 10% Owner | Buy | P | 8.00 | 813,474 | 6,507,792 | 2,611,564 | 1.8 M to 2.6 M (+45.24 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | NEW ENTERPRISE ASSOCIATES 10 L ... | 10% Owner | Buy | C | 0.00 | 58,692 | 0 | 1,798,090 | 1.7 M to 1.8 M (+3.37 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | NEW ENTERPRISE ASSOCIATES 10 L ... | 10% Owner | Buy | C | 0.00 | 1,479,058 | 0 | 1,739,398 | 260.3 K to 1.7 M (+568.13 %) |
| Oct 01 2014 | VTAE | Vitae Pharmaceutic ... | NEW ENTERPRISE ASSOCIATES 10 L ... | 10% Owner | Buy | C | 0.00 | 260,340 | 0 | 260,340 | 0 to 260.3 K |
| Sep 26 2014 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Option Exercise | A | 8.00 | 17,000 | 136,000 | 17,000 | |
| Sep 26 2014 | VTAE | Vitae Pharmaceutic ... | ROBERTS BRYAN E | Director | Option Exercise | A | 8.00 | 17,000 | 136,000 | 17,000 | |
| Sep 26 2014 | VTAE | Vitae Pharmaceutic ... | SANTINI GINO | Director | Option Exercise | A | 8.00 | 17,000 | 136,000 | 17,000 | |
| Sep 26 2014 | VTAE | Vitae Pharmaceutic ... | NEWHALL CHARLES W III | Director | Option Exercise | A | 8.00 | 17,000 | 136,000 | 17,000 | |
| Sep 26 2014 | VTAE | Vitae Pharmaceutic ... | Rowland Charles A Jr | Director | Option Exercise | A | 8.00 | 17,000 | 136,000 | 17,000 | |
| Sep 26 2014 | VTAE | Vitae Pharmaceutic ... | Barrett Peter | Director | Option Exercise | A | 8.00 | 17,000 | 136,000 | 17,000 | |
| Sep 26 2014 | VTAE | Vitae Pharmaceutic ... | Gunderson Robert V JR | Director | Option Exercise | A | 8.00 | 17,000 | 136,000 | 17,000 |